Related Experiment Video

Updated: Jun 13, 2026

Purification of Transcripts and Metabolites from Drosophila Heads
12:49

Purification of Transcripts and Metabolites from Drosophila Heads

Published on: March 15, 2013

State-of-the-art genomics approaches in toxicology

Paul Van Hummelen1, Jennifer Sasaki

  • 1MicroArray Facility, VIB, Herestraat 18, 3000 Leuven, Belgium. paulvh@eohsi.rutgers.edu

Mutation Research
|May 15, 2010
PubMed

Insights

Genomics accelerates drug development by profiling gene expression and identifying toxic effects. While promising, challenges in data analysis and implementation hinder its full potential in toxicology research.

Area of Science:

  • Pharmacogenomics
  • Toxicology
  • Biomarker Discovery

Background:

  • Genomics offers a powerful approach to streamline the drug development pipeline and minimize compound attrition.
  • Gene expression profiling induced by chemicals can establish dose-response relationships.
  • Toxicogenomics aids in identifying early toxicity biomarkers and elucidating mechanisms of action.

Purpose of the Study:

  • To explore the utility of genomics in enhancing drug development and environmental toxicology.
  • To highlight the potential of toxicogenomics in risk assessment and bridging preclinical data.

Main Methods:

  • Analysis of chemical-induced gene expression profiles.
  • Identification of sensitive biomarkers for early adverse effects.
  • Distinguishing genotoxic from non-genotoxic carcinogens.

Main Results:

  • Genomics can link chemical exposure to specific gene expression changes, aiding dose-response assessments.
  • Toxicogenomics facilitates the identification of early toxicity indicators and mechanistic insights.
  • Genomic data can help correlate in vitro findings with in vivo results for better risk assessment.

Conclusions:

  • Genomics and toxicogenomics show significant promise for improving drug development efficiency and environmental safety.
  • Addressing challenges in data analysis, interpretation, and accessibility is crucial for widespread adoption.
  • Effective integration of toxicogenomics into early drug discovery phases requires further development and team training.

More Related Videos

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors09:33

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors

Published on: February 7, 2018

Related Concept Videos

Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...